Back
Dianthus Therapeutics Vs. NovaBay Pharmaceuticals Industry Stock Comparison
Sell
40
DNTH
Dianthus Therapeutics
Last Price:
25.52
Seasonality Move:
19.62%
Sell
18
NBY
NovaBay Pharmaceuticals
Last Price:
0.58
Seasonality Move:
-6.61%
Sell
40
Dianthus Therapeutics (DNTH)
is a Sell
Is Dianthus Therapeutics a Buy, Sell or Hold?
- The current Dianthus Therapeutics [DNTH] share price is $25.57. The Score for DNTH is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- DNTH is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
18
NovaBay Pharmaceuticals (NBY)
is a Sell
Is NovaBay Pharmaceuticals a Buy, Sell or Hold?
- The current NovaBay Pharmaceuticals [NBY] share price is $0.57. The Score for NBY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- NBY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
DNTH Stock Price Chart
What is Dianthus Therapeutics's stock price today?
-
The Dianthus Therapeutics share price today is $25.57
The current trend is relatively stagnant and DNTH is experiencing buying pressure, which is a positive indicator for future bullish movement.
NBY Stock Price Chart
What is NovaBay Pharmaceuticals's stock price today?
-
The NovaBay Pharmaceuticals share price today is $0.57
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight selling pressure.
DNTH Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.83 | Sell |
| Relative Strength Index (14 RSI): | 51.38 | Buy |
| Chaikin Money Flow: | 209217 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (22.99 - 28.47) | Sell |
| Bollinger Bands (100): | (25.47 - 29.13) | Sell |
NBY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 35.79 | Sell |
| Chaikin Money Flow: | -12542 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
DNTH Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.63 | Buy |
| 20-day SMA: | 25.17 | Buy |
| 50-day SMA: | 26.68 | Sell |
| 200-day SMA: | 26.2 | Sell |
| 8-day EMA: | 24.37 | Buy |
| 20-day EMA: | 24.88 | Buy |
| 50-day EMA: | 26.08 | Sell |
| 200-day EMA: | 24.86 | Buy |
NBY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.63 | Sell |
| 20-day SMA: | 0.68 | Sell |
| 50-day SMA: | 0.67 | Sell |
| 200-day SMA: | 2.19 | Sell |
| 8-day EMA: | 0.62 | Sell |
| 20-day EMA: | 0.65 | Sell |
| 50-day EMA: | 0.7 | Sell |
| 200-day EMA: | 5.28 | Sell |
Dianthus Therapeutics Earnings Growth & DNTH Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $77.59 per share, and an increase next year of $2.44 per share.
Dianthus Therapeutics Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NovaBay Pharmaceuticals Technical Analysis
| Nov 19 | Nov 20 | Nov 21 | Nov 22 | Nov 25 | Nov 26 | Nov 27 | Nov 29 | Dec 2 | Dec 3 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | Dec | |||||||||
| 19 | 20 | 21 | 22 | 25 | 26 | 27 | 29 | 02 | 03 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||